Chapter 1. INFECTIOUS DISEASE DIAGNOSTICS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. INFECTIOUS DISEASE DIAGNOSTICS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. INFECTIOUS DISEASE DIAGNOSTICS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. INFECTIOUS DISEASE DIAGNOSTICS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. INFECTIOUS DISEASE DIAGNOSTICS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. INFECTIOUS DISEASE DIAGNOSTICS MARKET– By Product

6.1. Assays & Reagents

      6.1.1. Hepatitis

      6.1.2. Human Immunodeficiency Virus

      6.1.3. Influenza

      6.1.4. Others

6.2. Instruments

      6.2.1. Hepatitis

      6.2.2. Human Immunodeficiency Virus

      6.2.3. Influenza

      6.2.4. Others

6.3. Software

      6.3.1. Hepatitis

      6.3.2. Human Immunodeficiency Virus

      6.3.3. Influenza

      6.3.4. Others

Chapter 7. INFECTIOUS DISEASE DIAGNOSTICS MARKET– By Disease Type

7.1. Hepatitis

7.2. Human Immunodeficiency Virus

7.3. Influenza

7.4. Others

Chapter 8. INFECTIOUS DISEASE DIAGNOSTICS MARKET– By Technology

8.1. Immunodiagnostics

8.2. Clinical Microbiology

8.3. Polymerase Chain Reaction

8.4. Next Generation Sequencing

8.5. Others

Chapter 9. INFECTIOUS DISEASE DIAGNOSTICS MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. INFECTIOUS DISEASE DIAGNOSTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10